Skip to main content
Clinical Trials/NCT05658679
NCT05658679
Active, not recruiting
Not Applicable

Radiomics-based Detection and Outcome Prediction for Pancreatic Cancer

Ruijin Hospital0 sites2,000 target enrollmentJanuary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Cancer
Sponsor
Ruijin Hospital
Enrollment
2000
Primary Endpoint
5-year survival rate
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

The images of patients with pancreatic cancer were collected and analyzed based on the methodes of radiomics

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
December 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Weishen WANG

Principal Investigator

Ruijin Hospital

Eligibility Criteria

Inclusion Criteria

  • Gender unlimited, 18-80 years old;
  • Received abdominal imaging;
  • informed consent signed.

Exclusion Criteria

  • Pregnant / lactating women;
  • Contraindications of imaging examination。

Outcomes

Primary Outcomes

5-year survival rate

Time Frame: 1 week

Similar Trials